Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Gabriel T. Liberatore,Vernice Jackson-Lewis,Slobodanka Vukosavic,Allen S. Mandir,Miquel Vila,W. Geoffrey McAuliffe,Valina L. Dawson,Ted M. Dawson,Serge Przedborski
DOI: https://doi.org/10.1038/70978
IF: 82.9
1999-12-01
Nature Medicine
Abstract:MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) damages dopaminergic neurons as seen in Parkinson disease. Here we show that after administration of MPTP to mice, there was a robust gliosis in the substantia nigra pars compacta associated with significant upregulation of inducible nitric oxide synthase (iNOS). These changes preceded or paralleled MPTP-induced dopaminergic neurodegeneration. We also show that mutant mice lacking the iNOS gene were significantly more resistant to MPTP than their wild-type littermates. This study demonstrates that iNOS is important in the MPTP neurotoxic process and indicates that inhibitors of iNOS may provide protective benefit in the treatment of Parkinson disease.
biochemistry & molecular biology,cell biology,medicine, research & experimental
What problem does this paper attempt to address?